U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06798324) titled 'TDCS Plus Varenicline for Smoking Cessation' on Jan. 08.
Brief Summary: The goal of this clinical trial is to determine if active transcranial direct current stimulation (tDCS) plus varenicline is an effective, safe and accessible treatment option for smoking cessation. The main questions this trial aims to answer are:
1. Does active tDCS plus varenicline improve short-term and long-term smoking abstinence rates compared to sham tDCS plus varenicline?
2. Are the safety profiles between active tDCS plus varenicline and sham tDCS plus varenicline different?
The tDCS treatment schedule includes 10 daily sessions for the first 2 week...